CVS Health expects medical costs to remain high through the year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
CVS Health (CVS) PT Lowered to $63 at Deutsche Bank
August 8, 2024 12:31 PM EDTDeutsche Bank analyst George Hill lowered the price target on CVS Health (NYSE: CVS) to $63.00 (from $64.00) while maintaining a Hold rating.
The analyst comments "The Tumult Reaches a New High, as Guidance Reaches a New Low: CVS reported Q2 results and provided an updated earnings outlook with a... More
